ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
This field is for validation purposes and should be left unchanged.
go to the article

go back to the homepage

  • BIOCOM CARD
  • Newsletter
  • Advertising
  • Job Market
  • Shop
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Job Market
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Search
  • Menu Menu

ADVERTISEMENT

MoA of BioArtic's brain transporter technology that improved antibody uptake 70-fold in preclinical testsBioArctic AB
Neurodegeneration

Novartis secures US$30m+ licence option...

Following the commercial launch of BioArctic AB’s Alzheimer’s antibody lecanemab, the Swedish company has announced a new deal: it will receive an upfront payment of US$30m, granting the Swiss company … more ➔

Packshot of lecanemabEsai Pharma
Dementia

Alzheimer’s antibody Lecanemab launched...

Swedish BioArctic AB’s partner Eisai Pharma has started the European roll-out of their Alzheimer’s antibody lecanemab in Austria that will be followed by the German launch on September 1, 2025. more ➔

ADVERTISEMENT

Nathalie Moll, Director General, EFPIAEFPIA
US-EU trade conflict

US and EU confirm tariff deal on pharmac...

The US and EU have confirmed a trade agreement involving US import tariffs of 15% on prescription medicines. Generics manufacturers will face a maximum tariff of 2.5%. more ➔

Mode of action of sCD-83Mallia
Hair growth

Mallia Aesthetics is about to launch MAL...

Germany’s Mallia Aesthetics GmbH has announced the achievement of key regulatory milestones in preparation for the market launch of its sCD83-based hair growth stimulant, MAL-838, later this year. … more ➔

Christian Tidona, CEO and founder of BioMed XBioMed X
Metabolic Disorders

BioMed X and Novo Nordisk collaborate to...

Novo Nordisk has entered a collaboration with research institute BioMed X in an effort to regain market position lost to leading competitors in diabetes and obesity treatment. The partnership is focused … more ➔

European Biotechnology

1 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

Get a free sample copy | Abo
2 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

Get a free sample copy | Abo
3 / 4
EB424_Cover

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

Get a free sample copy | Abo
4 / 4
EB324_Titel

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … more ➔

Get a free sample copy | Abo
❮❯

ADVERTISEMENT

© AI
european-biotechnology-logo

NEWSLETTER


Stay up to date with the biotech industry!

Once a week, european-biotechnology.com brings you up to date on the latest developments in the biotech industry. In our free newsletter, you will find the latest news from business, research and politics, as well as lots of useful information and job vacancies.


Subscribe to our free newsletter!Subscribe here

R&D lab at Anocca ABAnocca AB
Immunoncology

Anocca raises €38.4m to advance TCR-T le...

Swedish immunoncology specialist Anocca AB has raised SEK440m (€38.36m) ahead of enrolling pancreatic cancer patients in a Phase I umbrella trial evaluating the safety of its T-cell receptor-engineered … more ➔

EdiMembre Co-Founders and former Merck employees, Tim Olsen (left) and Ryan Sylvia (right).© EdiMembre/Merck
Alternative Protein

Merck and mantro enter the foodtech market

The laboratory division of Merck KGaA has, in partnership with the German company builder Mantro GmbH, established EdiMembre Inc, a Massachusetts-based company set to deploy Merck’s technologies for … more ➔

ADVERTISEMENT

Sponsored Publications

1 / 2
Messegeschehen / Trade fair activity
POWTECH TECHNOPHARM

About POWTECH TECHNOPHARM

POWTECH TECHNOPHARM (Nuremberg, 23-25 September 2025) is the international trade fair for process engineering experts and a tailor-made technology platform for the pharmaceutical and life science … more ➔

2 / 2
product_02_bg[63]
Meteor Biotech

Unlocking the Future of Precision Biology with Spatial Cell Sorting

Spatial precision in cell analysis is revolutionizing biomedical research. SLACS (Spatially-resolved Laser Activated Cell Sorting) uniquely isolates live microniches within tissues, preserving spatial … more ➔

APPOINTMENTS

all appointments

EB.com_Alzecure_cecilia-wadellAlzeCure Pharma AB
Alzecure Pharma

New Head of Development

Swedish AlzeCure Pharma AB recently appointed Cecilia Wadell as Head of Development. She joins also the management team.
more ➔

eb.com_Sana_Alajmovic_CEO_Enzymatica_ABFotograf
Enzymatica AB

Successor found for CEO

Sana Alajmovic has been appointed as the new CEO of the Swedish company Enzymatica AB by the Board of Directors. The current CEO, Claus …
more ➔

EB.com_CMO_Centauri_Debra_Barker_klCentauri Therapeutics
Centauri Therapeutics

Experienced immunologist as CMO

Immunotherapy company Centauri Therapeutics Ltd, based in Alderley Park, Cheshire, UK, has announced the appointment of Dr Debra Barker …
more ➔

EB.com_Christian_Dowdeswell_ArcinovaArcinova
Arcinova

New managing director takes over

UK-based contract research, development and manufacturing organisation (CRDMO) Arcinova announced the appointment of Dr Christian Dowdeswell …
more ➔

Flags of US, EU and China painted on cracked walladobe stock photos - Tomas Ragina
Pharmaceutical Supply

Trump delays 250% tariffs on non-U.S. ph...

U.S. President Donald Trump’s announcement regarding new tariffs on pharmaceutical goods imported into the United States has been delayed. Despite the President’s threat early last week that a tariff … more ➔

ADVERTISEMENT

Nanocell's LNP delivery approachNanoCell Therapeutics Inc
Financing

CPTx and NanoCell Therapeutics secure Eu...

German CPTx GmbH, its CDMO Gxstrands, and the US start-up NanoCell Therapeutics have been awarded a Eurostars grant for their QUIET-CAR project, funded through the EU’s Horizon Europe programme and … more ➔

Mode of action of Pilatus Biosciences' monoclonal antibodyPilatus Biosciences
Cancer Immunotherapy

Pilatus Biosciences Enters Clinical Coll...

Pilatus Biosciences AG, a Swiss biotechnology company headquartered in Epalinges with operations in the United States and South Korea, has entered into a clinical trial collaboration with Roche AG. As … more ➔

All news
newsletter_link

EVENT


RMC2025nova-Institut GmbH
September 22 - September 24in Maternushaus

Renewable Materials Conference to be held in autumn

The international meeting place for the chemical, the plastics and materials industries will take place from 22 to 24 September 2025 in Siegburg/Cologne. It presents solutions and innovations for replacing fossil carbon with biomass, captured CO₂ and via recycling. ➔

© BIOCOM Interrelations GmbH
  • LinkedIn
  • Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top